HRT/ERT
Best Practice Recommendations

TARGET AUDIENCE

This activity has been designed to meet the educational needs of physician assistants and nurse practitioners in primary care with patients who anticipate or experience menopausal symptoms.

Original Release Date: December 2010
Expiration Date: December 31, 2011
Estimated Time to Complete this Activity: 1 hour
Medium: Printed journal and online CE/CME

PROGRAM OVERVIEW

The primary objective of this educational initiative is to provide clinicians in primary care with the most up-to-date information regarding best practice recommendations for use of hormone replacement therapy (HRT) to treat the symptoms of menopause.

EDUCATIONAL OBJECTIVES

After completing this activity, the participant should be better able to:

• Summarize concerns raised by unexpected findings from the Women’s Health Initiative, reported in 2002, regarding use of hormone therapy.
• Outline the generally agreed-upon benefits of hormone replacement therapy (HRT).
• Explain the timing hypothesis and an associated “critical therapeutic window” that may facilitate safe use of HRT in menopausal women.
• Discuss considerations of cardioprotection and neuroprotection in women who may require HRT for treatment of potentially severe menopausal symptoms.
• Describe the patient who is most likely to benefit from HRT use with minimal health risks, and under what circumstances.

FACULTY

Constance A. Burke Schmidt, MS, PA-C, is a Professor in the University of Detroit Mercy Physician Assistant Program and an adjunct faculty member at Baker College of Auburn Hills in Auburn Hills, Michigan. She is also Clinic Manager at FernCare Free Clinic in Ferndale, Michigan.

ACCREDITATION STATEMENT:

Physicians Assistants:
This program has been reviewed and is approved for a maximum of 1.0 hour of American Academy of Physician Assistants (AAPA) Category I CME credit by the Physician Assistant Review Panel. Approval is valid for one year from the issue date of December 2010. Participants may submit the self-assessment at any time during that period.

This program was planned in accordance with AAPA’s CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs. Successful completion of the self-assessment is required to earn Category I CME credit.

Successful completion is defined as a cumulative score of at least 70% correct.

Nurse Practitioners:
This program has been approved by the Nurse Practitioner Association New York State (The NPA) for 1.5 contact hours.

DISCLOSURE OF CONFLICTS OF INTEREST

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity: Constance A. Burke Schmidt, MS, PA-C, reported no significant financial relationship with any commercial entity related to this activity.

METHOD OF PARTICIPATION

The fee for participating and receiving CME credit for this activity is $10.00. During the period December 2010 through December 30, 2011, participants must:

1. read the learning objectives and faculty disclosures;
2. study the educational activity;
3. go to www.clinicianreviews.com, follow links to the posttest for this activity, and provide payment information via our secure server;
4. complete the 10-question posttest by recording the best answer to each question; and
5. record their response to each of the additional evaluation questions.

If you have any questions, e-mail CR.evaluations@qhc.com. Upon successful completion of an online posttest, with a score of 70% of better, and the completion of the online activity evaluation form, a statement of credit will be made available immediately.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AAPA, The NPA, and Quadrant HealthCom Inc. do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of AAPA, The NPA, or Quadrant HealthCom Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and the possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.